PATENT CLAIM ANALYSIS

Application Number: 16087861
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "210210"]

Abstract:
Disclosed is a new indole compound, in particular, the compound as shown in formula (I), and a preparation method, pharmaceutical composition and use thereof as an estrogen receptor down-regulator in preparing drugs for treating estrogen receptor-positive breast cancer.

Claim (Index 7):
The compound, the pharmaceutically acceptable salt, the hydrate or the prodrug thereof as defined in  claim 6 , wherein, R is selected from H, F, Cl, Br, I, OH, CN, NH 2 , COOH, C(\u2550O)NH 2 , or the group consisting of CH 3 , CH 3 CH 2 , S(\u2550O)CH 3 , each of which is optionally substituted with 1, 2, or 3 R\u2032.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16343387', '10465426', '10420399', '11585598', '12245305']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8438713663732585
- 35 USC 102 Novelty (BERT): 0.5536138860951074
- Combined Prediction Score: 0.8148456183454434
- Mean Citation Score: 398.579302
- Max Citation Score: 429.7016
- Similarity Product: 342.35571258249286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test